ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

House Measure Would Eliminate AHRQ, Rescind PCORI, Cut Outcomes Research, And Halt NIH’s Title 42 Hiring Program

July 20, 2012

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

NIH On R29 Phase-Out; Grant Review Appeals Process Changed

January 23, 1998

Kennedy Bill Leaves National Cancer Act intact, Creates NIH Construction Authority, Senior Service

April 1, 1988

Four UICC Programs Available For International Research

July 10, 1981

Foundation For COG Is New Name Of NCCF.

October 19, 2001